Kyoto, Japan

Noriko Iwamoto

This inventor holds 8 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Shimadzu Corporation. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriko Iwamoto. Retrieved from https://idiyas.com/inventor/noriko-iwamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 87.5

 

 

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Noriko Iwamoto: Innovator in Monoclonal Antibody Detection

Introduction

Noriko Iwamoto is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of monoclonal antibody detection, holding a total of 8 patents. Her innovative work has advanced analytical techniques that are crucial for various applications in biotechnology and medicine.

Latest Patents

Iwamoto's latest patents include a "Kit for preparing sample for detecting monoclonal antibody" and a "Method for improving result monoclonal antibody detection." The sample preparation kit provides a versatile analytical technique that is unaffected by the diversity of antibodies and other variables. It includes a porous body for immobilizing the monoclonal antibody, nanoparticles with immobilized protease, and a filtration membrane for extracting the reaction product. The detection method involves capturing the monoclonal antibody, conducting selective protease digestion, and detecting peptide fragments using liquid chromatography-mass spectrometry (LC-MS). These inventions enhance the applicability of detection methods for monoclonal antibodies.

Career Highlights

Throughout her career, Noriko Iwamoto has worked with esteemed organizations such as Shimadzu Corporation and the National Cancer Center. Her experience in these institutions has allowed her to develop and refine her innovative techniques in antibody detection.

Collaborations

Iwamoto has collaborated with notable colleagues, including Takashi Shimada and Megumi Takanashi. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Noriko Iwamoto's contributions to the field of monoclonal antibody detection exemplify her innovative spirit and dedication to scientific advancement. Her patents and collaborations continue to influence the biotechnology landscape, paving the way for future discoveries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…